Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48.9M
-
Number of holders
-
222
-
Total 13F shares, excl. options
-
36.1M
-
Shares change
-
+4.26M
-
Total reported value, excl. options
-
$2.6B
-
Value change
-
+$316M
-
Put/Call ratio
-
0.57
-
Number of buys
-
134
-
Number of sells
-
-67
-
Price
-
$71.86
Significant Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q2 2023
270 filings reported holding AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2023.
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) has 222 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.1M shares
of 48.9M outstanding shares and own 73.86% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (4.28M shares), VANGUARD GROUP INC (3.74M shares), BlackRock Inc. (2.72M shares), Fairmount Funds Management LLC (2.34M shares), BVF INC/IL (2.13M shares), FMR LLC (2.13M shares), RA CAPITAL MANAGEMENT, L.P. (1M shares), STATE STREET CORP (825K shares), ALETHEA CAPITAL MANAGEMENT, LLC (760K shares), and MILLENNIUM MANAGEMENT LLC (735K shares).
This table shows the top 222 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.